ACM
CNTB

ADAR1 Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

ADAR1 Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Sell
700,000
-42,400
-6% -$103K 0.08% 149
2026
Q1 		$1.95M Buy
+742,400
New +$1.94M 0.11% 122
2025
Q3 		– Sell
-10,300
Closed -$10.1K – 230
2025
Q2 		$10.1K Hold
10,300
– – ﹤0.01% 205
2025
Q1 		$5.67K Buy
+10,300
New +$9.54K ﹤0.01% 199

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

ADAR1 Capital Management's CNTB Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Connect Biopharma Holdings (CNTB) stake by 5.7% in Q2 2026, selling an estimated $103K and leaving 700,000 shares worth $1.67M. The position accounts for 0.08% of the portfolio, ranked #149.

ADAR1 Capital Management first reported a position in CNTB in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.95M in Q1 2026. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • ADAR1 Capital Management held 700,000 shares of Connect Biopharma Holdings worth $1.67M as of Q2 2026.
  • ADAR1 Capital Management sold 42,400 Connect Biopharma Holdings shares in Q2 2026, an estimated $103K.
  • Connect Biopharma Holdings made up 0.08% of ADAR1 Capital Management's portfolio in Q2 2026, its #149 holding.
  • ADAR1 Capital Management first reported a position in Connect Biopharma Holdings in Q1 2025 and has held it in 4 quarters since.
  • ADAR1 Capital Management's Connect Biopharma Holdings position peaked at $1.95M in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.